♦Interferon-beta-1b

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Interferon-beta-1b

♦Interferon-beta-1b (in-ter-feer’-on) Betaseron, rIFN-B Pregnancy Category C Mechanism of Action Not clearly understood; exerts antiviral and immunoregulatory biologic activities by binding to cell surface receptors. Indications To reduce the frequency…

read more

♦Interferon-beta-1a

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Interferon-beta-1a

♦Interferon-beta-1a (in-ter-feer’-on) Avonex Pregnancy Category C Mechanism of Action Not clearly understood; exerts biologic activities by binding to cell surface receptors. Indications To decrease physical disability and reduce the frequency…

read more

♦Interferon-alfa-2b

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Interferon-alfa-2b

♦Interferon-alfa-2b (in-ter-feer’-on) Intron-A, IFN-alpha 2 Pregnancy Category C Mechanism of Action Interferon exerts antitumor activities through antiviral replication, immunomodulatory, and antiproliferative biologic effects. Its direct antiproliferative properties may explain its…

read more

♦Interferon-alfa-2a

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Interferon-alfa-2a

♦Interferon-alfa-2a (in-ter-feer’-on) Roferon-A, rIFN-A Pregnancy Category C Mechanism of Action Not clearly understood; exerts antitumor activity through an-tiviral, antiproliferative, and immunomodulatory biologic effects. Indications ♦ Hairy cell leukemia and AIDS-related…

read more

♦Ifosfamide

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Ifosfamide

♦Ifosfamide (eye-fos’-fa-myde) Ifex Pregnancy Category D Mechanism of Action Ifosfamide is an alkylating agent that is cell cycle-nonspecific. It is an analogue of cyclophosphamide that acts by alkylating DNA and…

read more

♦Idarubicin Hydrochloride

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Idarubicin Hydrochloride

♦Idarubicin Hydrochloride (eye-da-roo’-bee-sin) Idamycin Pregnancy Category D Mechanism of Action Idarubicin is an intercalating analogue of daunorubicin, which inhibits nucleic acid synthesis and interacts with the enzyme topoisomerase. Indications Acute…

read more

♦Hydroxyurea

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Hydroxyurea

♦Hydroxyurea (hye-drox-ee-yoor-ee’-ya) Hydrea Pregnancy Category D Mechanism of Action Unknown. It is thought to cause an immediate inhibition of DNA synthesis without interfering with the synthesis of RNA or protein….

read more

♦Goserelin Acetate

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Goserelin Acetate

♦Goserelin Acetate (goe’-se-rel-in) Zoladex Pregnancy Category X Mechanism of Action This drug is an analogue for luteinizing hormone-releasing hormone and acts on the pituitary hormone to inhibit the secretion of…

read more

♦Gemcitabine

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Gemcitabine

♦Gemcitabine (gem-see’-ta-bean) Gemzar Pregnancy Category D Mechanism of Action Gemcitabine is a cell cycle-specific (S phase) cytotoxic agent that kills cells in the S phase undergoing DNA synthesis. It also…

read more

♦Flutamide

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Flutamide

♦Flutamide (floo’-ta-mide) Eulexin Pregnancy Category D Mechanism of Action This drug is a potent nonsteroidal agent that acts by inhibiting the uptake of androgen or the nuclear binding of androgen…

read more
Get Clinical Tree app for offline access